KARACHI: Consumers in Pakistan have appealed to the PTI government to control the surging prices of medicine lest the number of deaths start rising as drugs, including the life-saving ones, become at least 15% costlier.
The prices of basic medicines, including life-saving drugs, shot up by almost a fifth after the coronavirus lockdown, which has left people scared for lives due to affordability issues.
The News decided to visit Karachi's wholesale medicine market, which is the largest one in Pakistan, to see how shopkeepers and buyers are dealing with the rising drug prices.
Every pharmaceutical company has bumped up the prices of its medicines by at least 15% after the coronavirus lockdown, vendors at the wholesale market told The News. Consumers, they added, are worried due to the price surge since they are forced to buy basic medicines, including life-saving drugs, or face deterioration in health.
Therefore, consumers have appealed to the PTI regime to control the inflation lest the inability to afford medicines leads to deaths.
Separately, the Pakistan Chemists & Druggists Association (PCDA) says the Drug Regulatory Authority of Pakistan (DRAP) and the PTI regime have already given approval to pharmaceutical companies to increase drug prices in line with the consumer price index.
Medicare currently covers use of GLP-1 drugs such as Lilly's Mounjaro and Novo's Ozempic for conditions such as diabetes
Study finds depression symptoms among girls to be more than twice those of boys
WHO says outbreak affecting individuals of all age groups, with highest burden among those aged under 20
WHO says US' decision and reductions in official development assistance by some countries made slash much more acute
Dua Lipa marks fifth anniversary of ‘Future Nostalgia’ with ‘Physical’ remix release
Study co-author says pig liver "functioned really well" and "smoothly secreted bile" as well as producing key protein...